Clinical Trials
2 trialsNCT05729139 2023-08-09
Cemiplimab/Peg-Interferon-α in Advanced CSCC
Baptist Health South Florida
Phase 1 Withdrawn
NCT02218164 2022-10-07
Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed